TTR and chronic kidney disease: Thus, the pro-inflammatory and pro-fibrotic CTS-Na+/K+-ATPase signaling axis may provide a novel therapeutic target in settings, such as CKD where elevated CTS may induce renal inflammation and fibrosis.